BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35841885)

  • 1. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.
    Shi W; Wang L; Zhou T; Sastry M; Yang ES; Zhang Y; Chen M; Chen X; Choe M; Creanga A; Leung K; Olia AS; Pegu A; Rawi R; Schön A; Shen CH; Stancofski ED; Talana CA; Teng IT; Wang S; Corbett KS; Tsybovsky Y; Mascola JR; Kwong PD
    Structure; 2022 Sep; 30(9):1233-1244.e7. PubMed ID: 35841885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.
    Shi W; Wang L; Zhou T; Sastry M; Yang ES; Zhang Y; Chen M; Chen X; Choe M; Creanga A; Leung K; Olia AS; Pegu A; Rawi R; Shen CH; Stancofski ED; Talana CA; Teng IT; Wang S; Corbett KS; Tsybovsky Y; Mascola JR; Kwong PD
    bioRxiv; 2022 Jan; ():. PubMed ID: 35118472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies.
    Ng KW; Faulkner N; Finsterbusch K; Wu M; Harvey R; Hussain S; Greco M; Liu Y; Kjaer S; Swanton C; Gandhi S; Beale R; Gamblin SJ; Cherepanov P; McCauley J; Daniels R; Howell M; Arase H; Wack A; Bauer DLV; Kassiotis G
    Sci Transl Med; 2022 Jul; 14(655):eabn3715. PubMed ID: 35895836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
    Barnes CO; West AP; Huey-Tubman KE; Hoffmann MAG; Sharaf NG; Hoffman PR; Koranda N; Gristick HB; Gaebler C; Muecksch F; Lorenzi JCC; Finkin S; Hägglöf T; Hurley A; Millard KG; Weisblum Y; Schmidt F; Hatziioannou T; Bieniasz PD; Caskey M; Robbiani DF; Nussenzweig MC; Bjorkman PJ
    Cell; 2020 Aug; 182(4):828-842.e16. PubMed ID: 32645326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilized coronavirus spike stem elicits a broadly protective antibody.
    Hsieh CL; Werner AP; Leist SR; Stevens LJ; Falconer E; Goldsmith JA; Chou CW; Abiona OM; West A; Westendorf K; Muthuraman K; Fritch EJ; Dinnon KH; Schäfer A; Denison MR; Chappell JD; Baric RS; Graham BS; Corbett KS; McLellan JS
    Cell Rep; 2021 Nov; 37(5):109929. PubMed ID: 34710354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses.
    Peng Y; Liu Y; Hu Y; Chang F; Wu Q; Yang J; Chen J; Teng S; Zhang J; He R; Wei Y; Bostina M; Luo T; Liu W; Qu X; Li YP
    Front Immunol; 2022; 13():1056272. PubMed ID: 36618428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses.
    Deshpande A; Schormann N; Piepenbrink MS; Martinez Sobrido L; Kobie JJ; Walter MR
    FEBS J; 2023 Jul; 290(13):3422-3435. PubMed ID: 37014961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
    Hurlburt NK; Homad LJ; Sinha I; Jennewein MF; MacCamy AJ; Wan YH; Boonyaratanakornkit J; Sholukh AM; Jackson AM; Zhou P; Burton DR; Andrabi R; Ozorowski G; Ward AB; Stamatatos L; Pancera M; McGuire AT
    Commun Biol; 2022 Apr; 5(1):342. PubMed ID: 35411021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Tai W; Zheng J; Zhang X; Shi J; Wang G; Guan X; Zhu J; Perlman S; Du L
    Virus Res; 2023 Sep; 334():199156. PubMed ID: 37336390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model.
    Zhang Y; Zhang J; Li D; Mao Q; Li X; Liang Z; He Q
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain.
    Altomare CG; Adelsberg DC; Carreno JM; Sapse IA; Amanat F; Ellebedy AH; Simon V; Krammer F; Bajic G
    mBio; 2022 Jun; 13(3):e0358021. PubMed ID: 35467422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.
    Bianchini F; Crivelli V; Abernathy ME; Guerra C; Palus M; Muri J; Marcotte H; Piralla A; Pedotti M; De Gasparo R; Simonelli L; Matkovic M; Toscano C; Biggiogero M; Calvaruso V; Svoboda P; Cervantes Rincón T; Fava T; Podešvová L; Shanbhag AA; Celoria A; Sgrignani J; Stefanik M; Hönig V; Pranclova V; Michalcikova T; Prochazka J; Guerrini G; Mehn D; Ciabattini A; Abolhassani H; Jarrossay D; Uguccioni M; Medaglini D; Pan-Hammarström Q; Calzolai L; Fernandez D; Baldanti F; Franzetti-Pellanda A; Garzoni C; Sedlacek R; Ruzek D; Varani L; Cavalli A; Barnes CO; Robbiani DF
    Sci Immunol; 2023 Mar; 8(81):eade0958. PubMed ID: 36701425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.
    Piepenbrink MS; Park JG; Deshpande A; Loos A; Ye C; Basu M; Sarkar S; Khalil AM; Chauvin D; Woo J; Lovalenti P; Erdmann NB; Goepfert PA; Truong VL; Bowen RA; Walter MR; Martinez-Sobrido L; Kobie JJ
    PLoS Pathog; 2022 Jul; 18(7):e1010691. PubMed ID: 35862475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.
    Van Ert HA; Bohan DW; Rogers K; Fili M; Rojas Chávez RA; Qing E; Han C; Dempewolf S; Hu G; Schwery N; Sevcik K; Ruggio N; Boyt D; Pentella MA; Gallagher T; Jackson JB; Merrill AE; Knudson CM; Brown GD; Maury W; Haim H
    Microbiol Spectr; 2022 Feb; 10(1):e0267621. PubMed ID: 35080430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
    Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses.
    Halfmann PJ; Frey SJ; Loeffler K; Kuroda M; Maemura T; Armbrust T; Yang JE; Hou YJ; Baric R; Wright ER; Kawaoka Y; Kane RS
    EBioMedicine; 2022 Dec; 86():104341. PubMed ID: 36375316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.
    Li CJ; Chao TL; Chang TY; Hsiao CC; Lu DC; Chiang YW; Lai GC; Tsai YM; Fang JT; Ieong S; Wang JT; Chang SY; Chang SC
    Microbiol Spectr; 2022 Apr; 10(2):e0181421. PubMed ID: 35293796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.